Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-009259
Filing Date
2022-05-23
Accepted
2022-05-23 15:13:59
Documents
64
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20220331x10q.htm   iXBRL 10-Q 1109777
2 EX-31.1 rsls-20220331xex31d1.htm EX-31.1 11669
3 EX-31.2 rsls-20220331xex31d2.htm EX-31.2 11976
4 EX-32.1 rsls-20220331xex32d1.htm EX-32.1 9338
5 EX-32.2 rsls-20220331xex32d2.htm EX-32.2 9210
  Complete submission text file 0001558370-22-009259.txt   5195092

Data Files

Seq Description Document Type Size
6 EX-101.SCH rsls-20220331.xsd EX-101.SCH 37884
7 EX-101.CAL rsls-20220331_cal.xml EX-101.CAL 54480
8 EX-101.DEF rsls-20220331_def.xml EX-101.DEF 204837
9 EX-101.LAB rsls-20220331_lab.xml EX-101.LAB 351100
10 EX-101.PRE rsls-20220331_pre.xml EX-101.PRE 309777
58 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20220331x10q_htm.xml XML 712424
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37897 | Film No.: 22951229
SIC: 3841 Surgical & Medical Instruments & Apparatus